Oral propranolol and its impact on vital signs in hospitalized pediatric patients for the Management of Infantile Hemangiomas
Pediatric Dermatology · 2025
DOI: 10.1111/pde.15740 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Dermatology, 2025. Verfasst von Katelyn Rypka und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University of Minnesota, Minneapolis, Minnesota, USA. Hauptthemen laut MEDLINE: Propranolol, Vital Signs, Adrenergic beta-Antagonists, Skin Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCATS NIH HHS, National Institutes of Health's National Center for Advancing Translational Sciences.
Abstract (Originalsprache)
Background Infantile hemangiomas (IH) affect 2%–10% of the pediatric population. The current standard treatment for complicated IH is oral propranolol. Propranolol initiation protocols vary depending on institution and may occur in an inpatient setting for patients
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, University of Minnesota, Minneapolis, Minnesota, USA.
- Department of Dermatology, Minneapolis VA Medical Center, Minneapolis, Minnesota, USA.
- Department of Internal Medicine, Florida Atlantic University Charles E. Schmidt College of Medicine, Boca Raton, Florida, USA.
- Biostatistical Design and Analysis Center, Clinical and Translational Science Institute, University of Minnesota, Minneapolis, Minnesota, USA.
- Department of Pediatric Dermatology, University of Minnesota, Minneapolis, Minnesota, USA.
ORCID-Profile: Katelyn Rypka, Sheilagh Maguiness
Förderung
- NCATS NIH HHS
- National Institutes of Health's National Center for Advancing Translational Sciences
Zitieren
APA
Rypka, K., Bellefeuille, G., Wendland, Z., Paiewonsky, B., Freese, R., Maguiness, S., & Nicholson, C. (2025). Oral propranolol and its impact on vital signs in hospitalized pediatric patients for the Management of Infantile Hemangiomas. Pediatric Dermatology. https://doi.org/10.1111/pde.15740
Vancouver
Rypka K, Bellefeuille G, Wendland Z, Paiewonsky B, Freese R, Maguiness S, et al. Oral propranolol and its impact on vital signs in hospitalized pediatric patients for the Management of Infantile Hemangiomas. Pediatric Dermatology. 2025. doi:10.1111/pde.15740
BibTeX
@article{Rypka2025,
author = {Rypka, Katelyn and Bellefeuille, Gretchen and Wendland, Zachary and Paiewonsky, Briana and Freese, Rebecca and Maguiness, Sheilagh and Nicholson, Cynthia},
title = {Oral propranolol and its impact on vital signs in hospitalized pediatric patients for the Management of Infantile Hemangiomas},
journal = {Pediatric Dermatology},
year = {2025},
doi = {10.1111/pde.15740}
}
EUVIMED